Analysis of assessments at the Department of Clinical Cancer Genetics by cancer site and the importance of genetic findings in treatment planning
Introduction: The Institute of Oncology Ljubljana (IOL) provides genetic assessment for cancer patients who require test results for treatment planning and whenever there is a risk of a hereditary cancer syndrome. In this study, we aimed to analyse the trend of referrals of cancer patients and to a...
Saved in:
| Main Authors: | Nina Zavrl, Simona Hotujec, Srdjan Novaković, Stegel Vida, Mateja Krajc |
|---|---|
| Format: | Article |
| Language: | Slovenian |
| Published: |
Institute of Oncology Ljubljana
2024-12-01
|
| Series: | Onkologija |
| Subjects: | |
| Online Access: | https://revijaonkologija.si/Onkologija/article/view/558 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Outcomes of Poly(ADP–Ribose) Polymerase Inhibitors as Maintenance Therapy in Patients with Ovarian Cancer in the Southeastern Region of Korea
by: Hyeong In Ha, et al.
Published: (2024-10-01) -
DRG2 levels in prostate cancer cell lines predict response to PARP inhibitor during docetaxel treatment
by: Jeong Min Lee, et al.
Published: (2025-01-01) -
Genetic characterization of BRCA1 and BRCA2 variants in cancer and high-risk family screening cohorts in the UAE population
by: Abeer Arif Abdalla Abutalib Al Ali, et al.
Published: (2025-04-01) -
A case report of long-term successful use of maintenance therapy with PARP inhibitors in the primary treatment of advanced BRCA-associated ovarian cancer
by: О. N. Churuksaeva, et al.
Published: (2023-09-01) -
Cascade genetic testing in Lynch syndrome families
by: Lidija Praprotnik, et al.
Published: (2024-12-01)